Thoughts on impact factors and editing of medical journals.
作者信息
Gasparyan Armen Yuri
出版信息
Inflamm Allergy Drug Targets. 2010 Mar;9(1):2-5. doi: 10.2174/187152810791292908.
PMID:20230367
Abstract
摘要
相似文献
1
Thoughts on impact factors and editing of medical journals.关于医学期刊影响因子及编辑工作的思考
Inflamm Allergy Drug Targets. 2010 Mar;9(1):2-5. doi: 10.2174/187152810791292908.
2
Assessment of Preprint Policies of Top-Ranked Clinical Journals.顶级临床期刊预印本政策评估。
JAMA Netw Open. 2020 Jul 1;3(7):e2011127. doi: 10.1001/jamanetworkopen.2020.11127.
3
[Dear Authors and Dear Readers!].[亲爱的作者和亲爱的读者们！]
Ideggyogy Sz. 2009 Nov 30;62(11-12):364-5.
4
[Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication].[向生物医学期刊投稿的统一要求：生物医学出版的写作与编辑]
Rev Esp Cardiol. 2004 Jun;57(6):538-56. doi: 10.1016/s0300-8932(04)77145-6.
5
6
[Our annales and the European Society of Physical and Rehabilitation Medicine].[我们的年鉴与欧洲物理和康复医学学会]
Ann Readapt Med Phys. 2008 Dec;51(9):705-6. doi: 10.1016/j.annrmp.2008.10.001. Epub 2008 Oct 26.
7
A journal of a journal: The founding editor's perspective on The American Journal of Bioethics.一本期刊的期刊：创刊编辑对《美国生物伦理学杂志》的看法。
Am J Bioeth. 2010 Oct;10(10):1-2. doi: 10.1080/15265161.2010.544935.
8
Retraction policies of top scientific journals ranked by impact factor.按影响因子排名的顶级科学期刊的撤稿政策。
J Med Libr Assoc. 2015 Jul;103(3):136-9. doi: 10.3163/1536-5050.103.3.006.
9
Research misconduct policies of high impact biomedical journals.高影响力生物医学期刊的研究不端行为政策。
Account Res. 2006 Jul-Sep;13(3):247-58. doi: 10.1080/08989620600848199.
10
Requirements and definitions in conflict of interest policies of medical journals.医学期刊利益冲突政策中的要求和定义。
JAMA. 2009 Nov 25;302(20):2230-4. doi: 10.1001/jama.2009.1669.
引用本文的文献
1
Evaluating the effectiveness of citation count as a measure of methodological quality in esophagogastric surgery research: a comparative analysis with the MINORS score and levels of evidence.评估引用次数作为衡量食管胃外科研究方法学质量指标的有效性：与MINORS评分及证据水平的比较分析
Gastroenterol Hepatol Bed Bench. 2024;17(3):212-224. doi: 10.22037/ghfbb.v17i3.3005.
2
Impact factor JUMPS after the 2020 COVID-19 pandemic: a retrospective study in Dermatology journals.2020 年 COVID-19 大流行后影响因子飙升：皮肤科期刊的回顾性研究。
Ir J Med Sci. 2023 Aug;192(4):1711-1717. doi: 10.1007/s11845-022-03179-4. Epub 2022 Oct 3.
3
Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics.当前关于文献计量学的概念：影响因子、特征因子得分、CiteScore、SCImago 期刊排名、归一化引文影响、H 指数和替代计量学的简要回顾。
Ir J Med Sci. 2019 Aug;188(3):939-951. doi: 10.1007/s11845-018-1936-5. Epub 2018 Dec 3.
4
Factors Affecting Journal Quality Indicator in Scopus (SCImago Journal Rank) in Obstetrics and Gynecology Journals: a Longitudinal Study (1999-2013).影响妇产科期刊在Scopus（ScImago期刊排名）中期刊质量指标的因素：一项纵向研究（1999 - 2013年）
Acta Inform Med. 2014 Dec;22(6):385-8. doi: 10.5455/aim.2014.22.385-388. Epub 2014 Dec 19.
5
Comparison Between Impact Factor, Eigenfactor Metrics, and SCimago Journal Rank Indicator of Pediatric Neurology Journals.儿科神经学期刊的影响因子、特征因子指标与Scimago期刊排名指标的比较
Acta Inform Med. 2014 Apr;22(2):103-6. doi: 10.5455/aim.2014.22.103-106.
6
Diversity, value and limitations of the journal impact factor and alternative metrics.期刊影响因子和替代计量指标的多样性、价值和局限性。
Rheumatol Int. 2012 Jul;32(7):1861-7. doi: 10.1007/s00296-011-2276-1. Epub 2011 Dec 23.
7
Familiarizing with science editors' associations.熟悉科学编辑协会。
Croat Med J. 2011 Dec 15;52(6):735-9. doi: 10.3325/cmj.2011.52.735.
8
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.撰写叙事性生物医学综述：作者、同行评审者和编辑的考虑因素。
Rheumatol Int. 2011 Nov;31(11):1409-17. doi: 10.1007/s00296-011-1999-3. Epub 2011 Jul 29.
9
Biomedical journal editing: elements of success.生物医学期刊编辑：成功要素
Croat Med J. 2011 Jun;52(3):423-8. doi: 10.3325/cmj.2011.52.423.
10
J Young Pharm. 2011: What are we aiming at?《青年药学》2011年刊：我们的目标是什么？
J Young Pharm. 2011 Jan;3(1):1-3. doi: 10.4103/0975-1483.76412.
Zotero 插件